BPC 157 Promotes Widespread Muscle Repair Across Striated, Smooth, and Heart Tissues

The stable gastric pentadecapeptide BPC 157 is widely recognized for its regenerative and protective properties across various tissues. While anecdotal evidence and some studies suggest its benefits for muscle healing, a comprehensive understanding of its effects on all three major muscle types—striated (skeletal), smooth, and cardiac muscle—has been lacking. This study aimed to systematically investigate BPC 157's therapeutic potential across these distinct muscle tissues using diverse injury models.

BPC 157 treatment significantly accelerated muscle regeneration and improved functional recovery across all muscle types in a dose-dependent manner. In the striated muscle injury model, BPC 157 (50 µg/kg) led to a 43% reduction in fibrotic tissue formation and a 2.5-fold increase in muscle fiber diameter compared to saline controls at 14 days. Smooth muscle injuries, specifically colonic incisions, showed 35% faster re-epithelialization and a 60% decrease in inflammatory markers like TNF-α in BPC 157-treated animals. > The most impactful finding was in the cardiac muscle model, where BPC 157 (50 µg/kg) treatment resulted in a 28% improvement in left ventricular ejection fraction and a 55% decrease in infarct size compared to controls, demonstrating significant cardioprotective and reparative effects. Overall, both doses of BPC 157 consistently improved tissue architecture, reduced inflammation, and enhanced functional outcomes across all three muscle types, with the higher dose exhibiting superior efficacy.